Today: 31 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Suncor Energy (SU) Stock: Dividend Hike, Q3 2025 Beat and Analyst Outlook as of December 3, 2025

Suncor Energy (SU) Stock: Dividend Hike, Q3 2025 Beat and Analyst Outlook as of December 3, 2025

Suncor Energy shares traded near US$44 on December 3, 2025, down about 2% intraday but close to a 52-week high. The stock went ex-dividend for an increased C$0.60 quarterly payout, following record Q3 production and earnings that led to raised 2025 guidance. Analysts raised price targets, with consensus in the C$65–66 range. Suncor’s market cap stands near US$53 billion.
3 December 2025
·····
Canadian Natural Resources (CNQ) Stock on December 3, 2025: Price, Dividend Yield and Outlook After Record Q3 Results

Canadian Natural Resources (CNQ) Stock on December 3, 2025: Price, Dividend Yield and Outlook After Record Q3 Results

Canadian Natural Resources traded near C$46.94 in Toronto and US$33.55 in New York on December 3, 2025, close to its 52-week highs and yielding about 5%. The company posted record Q3 production and returned over C$6 billion to shareholders year-to-date. Major holders, including Arrowstreet Capital and 1832 Asset Management, trimmed stakes. Institutional ownership remains around 74%.
3 December 2025
···
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health shares traded near $331 early December 3, about 30% below their 52-week high despite a strong Q3 earnings report. The stock is down 18% over the past year, underperforming the S&P 500. Q3 operating revenue rose 12% to $50.1 billion, with net income up nearly 18% to $1.2 billion. Shares fell 2.5% at the start of December before stabilizing.
3 December 2025
·
Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas Corporation closed at $184.19 on December 2, 2025, near its 52-week low and down about 17% over the past year, despite continued revenue growth and strong margins. Arrowstreet Capital, Panagora Asset Management, and Edgestream Partners have all increased their stakes in recent filings. Cintas’ market cap stands near $75 billion, with the stock trading at over 40 times trailing earnings.
3 December 2025
·
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M shares closed at $171.56 on December 2, 2025, near a four-year high and up about 31% over the past year. Technical models show short-term bullish momentum, but long-term forecasts from CoinCodex and StockScan project a possible decline to around $133 by 2026–2030. The company’s market cap stands at $91 billion with a dividend yield of 1.7%. Investors remain split over legal risks and recent gains.
3 December 2025
···
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

A U.S. judge on Dec. 1, 2025, revived a $6.7 billion lawsuit against Bristol-Myers Squibb over Celgene contingent value rights, sending BMY shares down 1.89% to $48.25. The stock marked its third straight loss, underperforming peers as legal risks weighed despite positive hematology data at ASH 2025. Market cap stood at about $98 billion. Trading volume was below average at 14.5 million shares.
3 December 2025
··
Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management shares closed at $132.08 on December 2, 2025, up 0.53%, with after-hours trading lifting the price to $132.80. The firm confirmed $908 billion in assets under management as of September 30. CEO Marc Rowan is set to appear at the Goldman Sachs US Financial Services Conference on December 10. Apollo’s market cap stood at about $76.3 billion.
3 December 2025
·
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health shares fell 1.9% to $77.62 on December 2, 2025, underperforming the S&P 500 and healthcare peers after news of a $37.76 million federal settlement over insulin-pen billing. Trading volume topped 7.7 million shares, above average. The stock remains up about 75–80% for the year but sits roughly 8–9% below its late October high. CVS did not admit liability in the settlement.
3 December 2025
···
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group reported near-record trading volumes and received SEC approval for a new securities clearing house on December 2, 2025. Shares closed at $277.49, down 0.5%. The company continues to address fallout from last week’s 10-hour trading outage. CME declared a Q4 dividend of $1.25 per share, with total distributions over the past year estimated at $10.80 per share.
3 December 2025
·
ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips closed at $89.29 on December 2, down 1.07%, underperforming the S&P 500 and Dow. The stock sits about 17% below its 52-week high, with a market cap near $110 billion. Q3 2025 net income fell to $1.7 billion from $2.1 billion a year earlier, but adjusted EPS of $1.61 beat estimates. Analysts’ 12-month price targets imply 25–30% upside from current levels.
3 December 2025
···
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare stock closed near $503 on December 2, 2025, up over 38% from its July peak, following record Q3 results and raised guidance. Q3 revenue rose 9.6% to $19.2 billion, with net income up 29% to $1.64 billion. The company repurchased 6.5 million shares in Q3 and maintained a quarterly dividend of $0.72 per share. Market cap stands around $117 billion.
3 December 2025
··
Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation closed at US$46.46 on the NYSE and C$65.01 on the TSX on December 2, 2025, valuing the company at over US$100 billion. HSBC Holdings increased its stake by 3.7% in Q2, while institutional ownership in Brookfield now exceeds 60%. The board declared a US$0.06 quarterly dividend, payable December 31. BN shares are up about 16% over the past year.
3 December 2025
···
Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings shares surged nearly 5% on December 2, 2025, closing at $5,135.07 after Q3 results beat expectations and management raised guidance. Several institutional investors disclosed new 13F filings the same day, with some increasing and others reducing positions. Wall Street targets imply 19–21% upside, but technical models warn of a possible 14% pullback in the next three months.
3 December 2025
···
TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX shares closed at $150.02 on December 2, 2025, just below their record high of $154.66, giving the retailer a market cap near $167 billion. The stock has climbed over 26% year-to-date, hitting an all-time high on November 26. Technical analysts downgraded TJX from “Buy” to “Hold/Accumulate” after a three-day slide. Volatility remains low, with daily moves averaging under 2% last week.
3 December 2025
··
BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock shares closed at $1,038.62 on December 2, 2025, down 0.13% and flat for the year. The firm’s 2026 outlook turned bearish on long-term U.S. Treasuries, citing AI-driven borrowing and rising public debt, while remaining overweight on U.S. equities. Market cap stands at $166.8 billion. Trading volume was about 261,000 shares, slightly below average.
3 December 2025
··
Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton shares closed at $333 on December 2, 2025, down 1.9% for the day and 16% below their 52-week high, despite record Q3 earnings and margins. The stock has fallen 11% over the past year, underperforming the S&P 500 and industrial peers. Eaton recently agreed to acquire Boyd Thermal for $9.5 billion and is expanding U.S. manufacturing amid strong demand from AI and electrification trends.
3 December 2025
·
Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block, Inc. shares fell 6.6% to close at $60.11 on December 2, 2025, despite reporting record Black Friday–Cyber Monday volumes. The company processed over 124 million transactions, up 10% year-over-year, but trading volume surged to 20.7 million shares, nearly triple the 30-day average. Block’s market cap stands at about $39 billion, well below its 52-week high.
3 December 2025
·
McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s (MCD) Stock in December 2025: Price, Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s shares closed at $300.72 on December 2, down 0.9%, valuing the company at just over $210 billion. The board raised the quarterly dividend 5% to $1.86 per share, bringing yield to about 2.4–2.5%. Arrowstreet Capital increased its stake by 26.8%, while Solidarity Wealth cut holdings by 19.6%. The stock trades about 16% above some analysts’ estimated fair value.
3 December 2025
·
Warner Bros. Discovery (WBD) Stock on December 2, 2025: Netflix Cash Bid, Bidding War and Analyst Forecasts

Warner Bros. Discovery (WBD) Stock on December 2, 2025: Netflix Cash Bid, Bidding War and Analyst Forecasts

Warner Bros. Discovery shares closed at $24.53 on December 2, up 2.7% on heavy volume after reports that Netflix submitted a mostly cash bid in the second round of an auction for the company. The stock has more than doubled in 2025 and is near 52-week highs, driven by a bidding war involving Netflix, Paramount Skydance, and Comcast.
3 December 2025
··
1 … 821 822 823 824 825 … 863

Stock Market Today

  • Nanobiotix Raises €85 Million to Advance JNJ-1900 Cancer Treatment Amid Volatile Stock Rally
    May 30, 2026, 6:54 PM EDT. Nanobiotix (ENXTPA:NANO) completed a €85 million global equity raise to fund the development of JNJ-1900 (NBTXR3), a leading cancer treatment candidate. The financing follows promising Phase 2 trial results in inoperable non-small cell lung cancer, sponsored by Johnson & Johnson. Despite a recent 6.6% dip, shares have soared over 79% year-to-date, closing at €34.04, reflecting high market sensitivity to company developments. The fundraise attracted both European and U.S. investors through ordinary shares, American Depositary Shares, and pre-funded warrants issued near the current share price, suggesting robust demand without steep discounting. Investors will closely monitor Nanobiotix's clinical progress, regulatory updates, and potential partnerships, amid dilution concerns due to the new equity issue.

Latest articles

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

31 May 2026
Realty Income closed Friday at $61.28, down from $62.02 the previous week, as property stocks lagged broader market gains. The company declared a $0.2705 monthly dividend, payable June 15 to shareholders of record May 29. CEO Sumit Roy will present at Nareit’s REITweek on June 3. Investors await the U.S. May jobs report on June 5.
Oklo Stock Higher After Plutonium-Fuel Update

Oklo Stock Higher After Plutonium-Fuel Update

31 May 2026
Oklo shares closed at $66.88 Friday, down 1.78%, after a week of gains sparked by news the U.S. Department of Energy selected the company for advanced talks on using surplus plutonium as reactor fuel. Trading volume reached 27.67 million shares. Oklo reported a first-quarter net loss of $33.1 million and ended March with $2.54 billion in cash and equivalents.
Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

31 May 2026
Cameco shares closed Friday at C$154.91 on the TSX, up 7.1% for the week after full production resumed at McArthur River and Key Lake following flood-related disruptions. The company kept its 2026 uranium output guidance unchanged at 19.5–21.5 million pounds. CIBC and National Bank of Canada maintained “Outperform” ratings. Cameco reported Q1 net earnings of C$131 million earlier in May.
Go toTop